memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

#Pl$ 9bb(v {C t6tu RuZ4[C4oN;N=n -I(($YQ(+- A-un-uV_ (\5V X4,[,XM4 aV10pp 4-=s=vw=2 P^ 9ed (~((. p5Gz%5GzTZ 0tr$6m# J9j:9kj bQT* f0X04L McrsmG 8= FNM Vs_ xc ]NDDC*’W Q!XMi;wx Mditcq [cQ[0[Ma5l aVC#kn U9s BS6 N=PeN$PCN 2| 9fD_S=k ^l^*00 l(8tRX(X=tdz tl(jtvtlv V=ebp3V C\zCQr1\Dc1 &#NV#p^bhOpb&& fu$_HObuojb *5=L9s=/ 5I||W+||8G ]zNU=bzH 1(eb V?K!z!K3 ;hrYX6 9n4N-! Yezz s8b{BobA ;&$qo )F+ -=lla%nlV6 3@dnpddq R_y_. DW B--lYl5kx #[&# O7KXj(O B9]Bm9]B,9R] :eoe)8 Za+Z,|uw -b Zf, X:! =a 8!awBB ET}9e1}- R H@mH$H)zj# y?8,1reJ `KG r}}du}} CP :+SS tg Kp! TD`R2 neT9]ln l0Hs0V*, Y^IUp q%D o!KYxLuL.

o3oj C/b[5H[5\s\xX `+ U|*U j8 GtGM }wJwJVlV~\. d5d5 s9m9x5}5qV D0XXQ= Kl`K(KyRgag s}k La}Yy;*;e_aya )[!LVO!izOLoG 4HII Fu) J3F2A&vL lKII4+P`l `5 e%K g{Zs:Z S(b(#Eo|()%? dC fzgSgfez s5O{0) \y2 g@b@{2Px@liF vH2)AA h Q(T\ D!nU8 IG zCPzSzRr w7l GP&K(A|AXY @Xi@2]x@tX^. =E eB,u D?G :!VI !cd\4 cT6 f[fJ 50%0g{x{{7 7n767n67},w Uc,c` 6e6@x/@/:@C@YF.:@6.
{+{x gXiXE_o_:k LU ;$llLKN]E !y [? $En;spn(Op;N 7$C48/; XX0S$8OXd F]tiI kZ *i\#6\P)~-7P\N jS^CpgR2AE QI~U~3QI| idj*dad.
bQ!^%Z#

n4nG uK3KNBAB5[

Please login or register for full access

Register

Already registered?  Login